Prosecution Insights
Last updated: August 18, 2026

Examiner: MARTIN, PAUL C

Tech Center 1600 • Art Units: 1653 1657

This examiner grants 42% of resolved cases

Performance Statistics

41.8%
Allow Rate
-18.2% vs TC avg
888
Total Applications
+21.7%
Interview Lift
1225
Avg Prosecution Days
Based on 825 resolved cases, 2023–2026

Rejection Statute Breakdown

5.7%
§101 Eligibility
11.4%
§102 Novelty
53.8%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18811838 Enzymatic and Acid Methods for Individualizing Trichomes Non-Final OA The Procter & Gamble Company
18027821 METHOD OF APPLYING FORCE TO ORGANISM AND DEVICE FOR APPLYING FORCE TO ORGANISM Final Rejection NIKON CORPORATION
17778765 IMMUNOMAGNETIC SEQUENTIAL ULTRAFILTRATION PLATFORM FOR ENRICHMENT AND PURIFICATION OF EXTRACELLULAR VESICLES FROM BIOFLUIDS Final Rejection OHIO STATE INNOVATION FOUNDATION
17613994 CELL STORAGE AND TRANSPORTATION MEDIUM, SYSTEM, AND METHOD OF CELL AGGREGATES Non-Final OA CORNING INCORPORATED
17616427 IMAGING SAMPLE FOR MASS SPECTROMETER AND METHOD FOR PRODUCING SAME Non-Final OA ASAHI KASEI KABUSHIKI KAISHA
18560940 METHOD AND APPARATUS FOR IMAGING A BIOLOGICAL SAMPLE Non-Final OA LEICA MICROSYSTEMS CMS GMBH
16289118 Method for Enhancing Red Blood Cell Quality and Survival During Storage Non-Final OA Trustees of Dartmouth College
18181023 OPTIMIZATION OF FLUID POOLING Final Rejection Fenwal, Inc.
18863125 PEST CONTROL COMPOSITIONS Non-Final OA Rohm and Haas Company
17909067 COMPOSITION FOR EXTENDING VIABLE PRESERVATION AND SHELF-LIFE OF ORGANS AND TISSUES Non-Final OA University of Notre Dame du Lac
18045126 DECELLULARIZED VASCULAR GRAFTS, METHODS, AND BENCH-TOP MODELS OF ATHEROSCLEROSIS Final Rejection Wayne State University
18029391 3D STRUCTURES FOR CELL GROWTH Non-Final OA ACADEMISCH ZIEKENHUIS MAASTRICHT
18260418 BLASTOCYST-LIKE CELL AGGREGATE AND METHODS Non-Final OA IMBA - INSTITUT FÜR MOLEKULARE BIOTECHNOLOGIE GMBH
17588925 Lp-PLA2 ASSAYS AND COMPOSITION WITH DETERGENT Final Rejection CLEVELAND HEARTLAB, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month